Signature »

Enlivex Therapeutics shares owned by Signature

Quarter-by-quarter ownership of Enlivex Therapeutics (ENLV) shares owned by Signature from 13F filings

Historical chart of Signature investment in Enlivex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enlivex Therapeutics held by Signature consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enlivex Therapeutics by Signature

Quarter filed Position value Share count Share price at filing
2024-09-30 $5.0k 3.0k 1.68

More positions owned by Signature

Ishares Tr Rus 1000 Grw Etf (IWF)
Ishares Tr Core S&p Us Vlu (IUSV)
Vanguard Specialized Funds Div App Etf (VIG)
J P Morgan Exchange Traded F Us Qualty Fctr (JQUA)
Ishares Tr Core Msci Eafe (IEFA)
Vanguard Index Fds Small Cp Etf (VB)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr National Mun Etf (MUB)
Apple (AAPL)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Index Fds Growth Etf (VUG)

View all positions for Signature

Top funds holding Enlivex Therapeutics

Armistice Capital
Morgan Stanley
Renaissance Technologies
Citadel Advisors
Goldman Sachs Group
Geode Capital Management
Wells Fargo & Company
Group One Trading
Steward Partners Investment Advisory
Signature
Jpmorgan Chase & Co
Activest Wealth Management
SRS Capital Advisors
Advisor Group Holdings
Red Tortoise

View all funds holding Enlivex Therapeutics